Dr. Campbell received his medical training at Washington University, from professors who pioneered American research in causes of pulmonary emphysema in general, and alpha1-antitrypsin deficiency in particular. He has been involved in basic and clinical research related to alpha1-antitrypsin deficiency since the mid-1980s and is one of the world’s thought leaders regarding this condition. Dr. Campbell has directed Alpha1Center, a clinical laboratory devoted to detecting alpha1-antitrypsin deficiency, since 1991.
This #GivingTuesday, your donation means more than ever. Your support goes directly to our clean air and lung health initiatives, including ending COVID-19. For a limited time every donation you make will be matched, up to $25,000, thanks to Dyson.